Literature DB >> 25693438

[Effects of alpha lipoic acid and pirfenidone on liver cells antioxidant modulation against oxidative damage].

José Macias-Barragan, Alessandra Caligiuri, Jesús García-Banuelos, Maurizio Parola, Massimo Pinzani, Juan Armendariz-Borunda.   

Abstract

BACKGROUND: Liver fibrogenic processes are related to cellular redox state. Glutathione (GSH) is the major cellular antioxidant. GSH induced activation could be related to antifibrogenic effects. AIM: To explore the association between the antifibrogenic effect and pro-antioxidant mechanisms of alpha-lipoic acid (ALA) and pirfenidone (PFD).
MATERIAL AND METHODS: HepG2 cells and primary HSC cultures were exposed to menadione 0.1 μM (MEN) as oxidative stress inducer and treated to ALA (5 mM) or PFD (10 μM, 100 μM y 1000 μM).
RESULTS: In HSC, PFD decreased cell proliferation and the expression of COL1A1, TGF-β1, TIMP1, IL6, TNFα and MCP1 induced by MEN. Furthermore it was confirmed that ALA and PFD activate diverse antioxidants mediators, however MEN decreases this response. Then, MEN, ALA and PFD induce an antioxidant response, the first one as a response to injury and the latter two as pro-antioxidant inducers. Therefore, when cells are exposed to oxidative stress, endogenous systems activate a battery of mediators that increase the antioxidant potential. When these cells are treated with ALA and PFD, de novo formation of protective genes decreases since previous elicited protection induced in response to injury, enhance ALA and PFD effects.
CONCLUSION: Regardless of the route of action, ALA and PFD induce the biosynthesis of antioxidants mediators which is associated with modulation of fibrogenic processes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25693438     DOI: 10.4067/S0034-98872014001200009

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  5 in total

1.  Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.

Authors:  Yuan Liu; Fuai Lu; Lirong Kang; Zhihua Wang; Yongfu Wang
Journal:  BMC Pulm Med       Date:  2017-04-18       Impact factor: 3.317

2.  Evaluation of the anti-Toxoplasma gondii Activity of Hederagenin in vitro and in vivo.

Authors:  Run-Hui Zhang; Runhao Jin; Hao Deng; Qing-Kun Shen; Zhe-Shan Quan; Chun-Mei Jin
Journal:  Korean J Parasitol       Date:  2021-06-21       Impact factor: 1.341

3.  Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer Nanoparticles.

Authors:  Sara Maslanka Figueroa; Daniel Fleischmann; Sebastian Beck; Achim Goepferich
Journal:  Pharm Res       Date:  2020-02-24       Impact factor: 4.200

4.  Effects of alpha-lipoic acid on the behavior, serum indicators, and bone quality of broilers under stocking density stress.

Authors:  Huihui Ma; Bin Xu; Wenjia Li; Fengxian Wei; Woo Kyun Kim; Chongxiao Chen; Quanyou Sun; Chen Fu; Gaili Wang; Shaoyu Li
Journal:  Poult Sci       Date:  2020-06-16       Impact factor: 3.352

Review 5.  Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge.

Authors:  Jorge Gutiérrez-Cuevas; Ana Sandoval-Rodriguez; Alejandra Meza-Rios; Hugo Christian Monroy-Ramírez; Marina Galicia-Moreno; Jesús García-Bañuelos; Arturo Santos; Juan Armendariz-Borunda
Journal:  Cells       Date:  2021-03-12       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.